Full website launching soon
BIODELPHIS Therapeutics™
EPFL spinoff advancing first-in-class Antibody-Peptide Inhibitor Conjugates (APIC) to deliver precise, next-generation protease-targeted therapies.
Address
Avenue Recordon 32
c/o Aaron Petruzzella
1004 Lausanne
SUISSE
Powered by Ascent